Lindbrook Capital, LLC Abiomed Inc Transaction History

Lindbrook Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$242.49 - $301.46 $18,671 - $23,212	77 Added 452.94%	94 $23,000
Q2 2022 Aug 01, 2022	SELL	$224.73 - $338.64 $449 - $677	-2 Reduced 10.53%	17 $4,000
Q1 2022 Apr 21, 2022	BUY	$277.25 - $366.29 $554 - $732	2 Added 11.76%	19 $6,000
Q4 2021 Jan 18, 2022	SELL	$300.63 - $371.35 $601 - $742	-2 Reduced 10.53%	17 $6,000
Q2 2021 Jul 27, 2021	BUY	$262.71 - $351.17 $2,364 - $3,160	9 Added 90.0%	19 $6,000
Q1 2021 Apr 28, 2021	BUY	$285.92 - $355.13 $1,143 - $1,420	4 Added 66.67%	10 $3,000
Q4 2020 Jan 27, 2021	BUY	$251.88 - $324.2 $503 - $648	2 Added 50.0%	6 $2,000
Q1 2020 Apr 22, 2020	BUY	$130.51 - $196.01 $522 - $784	4 New	4 $1,000
Q3 2019 Oct 31, 2019	SELL	$175.89 - $279.23 $527 - $837	-3 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$281.08 - $444.25 $843 - $1,332	3 New	3 $0

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.